zenodoopen

Raw data of the EFSA NAMs Project on Tebufenpyrad, Part 1 (Annex B) (GP/EFSA/SCER/2020/02) (Henri et al., 2023)

<p>Raw data of the <em>in vitro</em> experiments produced in the context of the EFSA Pilot Project on 'New Approach Methodologies (NAMs) for Tebufenpyrad Risk Assessment. Part 1. Development of Physiologically-Based Kinetic (PBK) Model Coupled With Pulmonary and Dermal Exposure’ outsourced to ANSES (Annex B) (GP/EFSA/SCER/2020/02) (Henri et al., 2023).</p>

ShareScore

40/100

Overall dataset sharing score

Score breakdown

These five areas show where the dataset supports — or may limit — practical reuse.

Stewardship: 8
Harmonization: 4
Access: 16
Reuse readiness: 8
Engagement: 4

Topics

Tebufenpyrad Physiologically-Based Kinetic model Quantitative In Vitro to In Vivo Extrapolation Mitochondrial Toxicity Neurotoxicity

Dataset details

Repository: zenodo
Published: January 15, 2023
License: cc-by-4.0
DOI: 10.5281/zenodo.7446301

Scored with release 0.9.0

Raw data of the EFSA NAMs Project on Tebufenpyrad, Part 1 (Annex B) (GP/EFSA/SCER/2020/02) (Henri et al., 2023)

Score breakdown

Topics

Dataset details

Your academic CV and NIH biosketch